Acid Ceramidase (ASAH1) Represses Steroidogenic Factor 1-Dependent Gene Transcription in H295R Human Adrenocortical Cells by Binding to the Receptor

REFERENCES

• Albi E, Magni MP. 1997. Chromatin neutral sphingomyelinase and its role in hepatic regeneration. Biochem. Biophys. Res. Commun. 236:29–33.
   PubMedGoogle Scholar
• Albi E, Magni MV. 1999. Sphingomyelin synthase in rat liver nuclear membrane and chromatin. FEBS Lett. 460:369–372.
   PubMedGoogle Scholar
• Bernardo K, et al. 1995. Purification, characterization, and biosynthesis of human acid ceramidase. J. Biol. Chem. 270:11098–11102.
   PubMed Web of Science ®Google Scholar
• Blind RD, Suzawa M, Ingraham HA. 2012. Direct modification and activation of a nuclear receptor-PIP2 complex by the inositol lipid kinase IPMK. Sci. Signal. 5:ra44. https://doi.org/10.1126/scisignal.2003111.
   PubMed Web of Science ®Google Scholar
• Børud B, et al. 2002. The nuclear receptor coactivators p300/CBP/cointegrator-associated protein (p/CIP) and transcription intermediary factor 2 (TIF2) differentially regulate PKA-stimulated transcriptional activity of steroidogenic factor 1. Mol. Endocrinol. 16:757–773.
   PubMedGoogle Scholar
• Chen WY, Juan LJ, Chung BC. 2005. SF-1 (nuclear receptor 5A1) activity is activated by cyclic AMP via p300-mediated recruitment to active foci, acetylation, and increased DNA binding. Mol. Cell. Biol. 25:10442–10453.
   PubMedGoogle Scholar
• Chen WY, Lee WC, Hsu NC, Huang F, Chung BC. 2004. SUMO modification of repression domains modulates function of nuclear receptor 5A1 (steroidogenic factor-1). J. Biol. Chem. 279:38730–38735.
   PubMedGoogle Scholar
• Chuderland D, Konson A, Seger R. 2008. Identification and characterization of a general nuclear translocation signal in signaling proteins. Mol. Cell 31:850–861.
   PubMed Web of Science ®Google Scholar
• Crawford PA, Dorn C, Sadovsky Y, Milbrandt J. 1998. Nuclear receptor DAX-1 recruits nuclear receptor corepressor N-CoR to steroidogenic factor 1. Mol. Cell. Biol. 18:2949–2956.
   PubMed Web of Science ®Google Scholar
• Crawford PA, Polish JA, Ganpule G, Sadovsky Y. 1997. The activation function-2 hexamer of steroidogenic factor-1 is required, but not sufficient for potentiation by SRC-1. Mol. Endocrinol. 11:1626–1635.
   PubMedGoogle Scholar
• Cuvillier O. 2002. Sphingosine in apoptosis signaling. Biochim. Biophys. Acta 1585:153–162.
   PubMed Web of Science ®Google Scholar
• Dammer EB, Leon A, Sewer MB. 2007. Coregulator exchange and sphingosine-sensitive cooperativity of steroidogenic factor-1, general control nonderepressed 5, p54, and p160 coactivators regulate cyclic adenosine 3′,5′-monophosphate-dependent cytochrome P450c17 transcription rate. Mol. Endocrinol. 21:415–438.
   PubMed Web of Science ®Google Scholar
• Desclozeaux M, Krylova IN, Horn F, Fletterick RJ, Ingraham HA. 2002. Phosphorylation and intramolecular stabilization of the ligand binding domain in the nuclear receptor steroidogenic factor 1. Mol. Cell. Biol. 22:7193–7203.
   PubMed Web of Science ®Google Scholar
• Dubbink HJ, et al. 2006. Androgen receptor ligand-binding domain interaction and nuclear receptor specificity of FXXLF and LXXLL motifs as determined by L/F swapping. Mol. Endocrinol. 20:1742–1755.
   PubMedGoogle Scholar
• Duverger E, Pellerin-Mendes C, Mayer R, Roche AC, Monsigny M. 1995. Nuclear import of glycoconjugates is distinct from the classical NLS pathway. J. Cell Sci. 108(Part 4):1325–1332.
   PubMedGoogle Scholar
• Eliyahu E, Park JH, Shtraizent N, He X, Schuchman EH. 2007. Acid ceramidase is a novel factor required for early embryo survival. FASEB J. 21:1403–1409.
   PubMed Web of Science ®Google Scholar
• Ferlinz K, et al. 2001. Human acid ceramidase: processing, glycosylation, and lysosomal targeting. J. Biol. Chem. 276:35352–35360.
   PubMed Web of Science ®Google Scholar
• Glass CK, Rosenfeld MG. 2000. The coregulator exchange in transcriptional functions of nuclear receptors. Genes Dev. 14:121–141.
   PubMed Web of Science ®Google Scholar
• Görlich D. 1997. Nuclear protein import. Curr. Opin. Cell Biol. 9:412–419.
   PubMed Web of Science ®Google Scholar
• Hait NC, et al. 2009. Regulation of histone acetylation in the nucleus by sphingosine-1-phosphate. Science 325:1254–1257.
   PubMed Web of Science ®Google Scholar
• Hammer GD, et al. 1999. Phosphorylation of the nuclear receptor SF-1 modulates cofactor recruitment: integration of hormone signaling in reproduction and stress. Mol. Cell 3:521–526.
   PubMed Web of Science ®Google Scholar
• Heery DM, Kalkhoven E, Hoare S, Parker MG. 1997. A signature motif in transcriptional co-activators mediates binding to nuclear receptors. Nature 387:733–736.
   PubMed Web of Science ®Google Scholar
• Heldring N, et al. 2007. Structural insights into corepressor recognition by antagonist-bound estrogen receptors. J. Biol. Chem. 282:10449–10455.
   PubMed Web of Science ®Google Scholar
• Hsia EY, Goodson ML, Zou JX, Privalsky ML, Chen HW. 2010. Nuclear receptor coregulators as a new paradigm for therapeutic targeting. Adv. Drug Deliv. Rev. 62:1227–1237.
   PubMedGoogle Scholar
• Hu X, Lazar MA. 1999. The CoRNR motif controls the recruitment of corepressors by nuclear hormone receptors. Nature 402:93–96.
   PubMed Web of Science ®Google Scholar
• Huwiler A, Kolter T, Pfeilschifter J, Sandhoff K. 2000. Physiology and pathophysiology of sphingolipid metabolism and signaling. Biochim. Biophys. Acta 1485:63–99.
   PubMed Web of Science ®Google Scholar
• Ishihara SL, Morohashi K. 2005. A boundary for histone acetylation allows distinct expression patterns of the Ad4BP/SF-1 and GCNF loci in adrenal cortex cells. Biochem. Biophys. Res. Commun. 329:554–562.
   PubMedGoogle Scholar
• Ito M, Yu R, Jameson JL. 1997. DAX-1 inhibits SF-1-mediated transactivation via a carboxy-terminal domain that is deleted in adrenal hypoplasia congenita. Mol. Cell. Biol. 17:1476–1483.
   PubMed Web of Science ®Google Scholar
• Ito M, Yu RN, Jameson JL. 1998. Steroidogenic factor-1 contains a carboxy-terminal transcriptional activation domain that interacts with steroid receptor coactivator-1. Mol. Endocrinol. 12:290–301.
   PubMedGoogle Scholar
• Jacob AL, Lund J, Martinez P, Hedin L. 2001. Acetylation of steroidogenic factor 1 protein regulates its transcriptional activity and recruits the coactivator GCN5. J. Biol. Chem. 276:37659–37664.
   PubMed Web of Science ®Google Scholar
• Komatsu T, et al. 2004. Small ubiquitin-like modifier 1 (SUMO-1) modification of the synergy control motif of Ad4 binding protein/steroidogenic factor 1 (Ad4BP/SF-1) regulates synergistic transcription between Ad4BP/SF-1 and Sox9. Mol. Endocrinol. 18:2451–2462.
   PubMed Web of Science ®Google Scholar
• Krylova IN, et al. 2005. Structural analyses reveal phosphatidyl inositols as ligands for the NR5 orphan receptors SF-1 and LRH-1. Cell 120:343–355.
   PubMed Web of Science ®Google Scholar
• Kumar R, Gururaj AE, Vadlamudi RK, Rayala SK. 2005. The clinical relevance of steroid hormone receptor corepressors. Clin. Cancer Res. 11:2822–2831.
   PubMedGoogle Scholar
• Lala DS, Rice DA, Parker KL. 1992. Steroidogenic factor I, a key regulator of steroidogenic enzyme expression, is the mouse homolog of fushi tarazu-factor I. Mol. Endocrinol. 6:1249–1258.
   PubMedGoogle Scholar
• Ledeen RW, Wu G. 2008. Nuclear sphingolipids: metabolism and signaling. J. Lipid Res. 49:1176–1186.
   PubMed Web of Science ®Google Scholar
• Li D, et al. 2007. Cyclic AMP-stimulated interaction between steroidogenic factor 1 and diacylglycerol kinase θ facilitates induction of CYP17. Mol. Cell. Biol. 27:6669–6685.
   PubMedGoogle Scholar
• Li LA, et al. 1999. Function of steroidogenic factor 1 domains in nuclear localization, transactivation, and interaction with transcription factor TFIIB and c-Jun. Mol. Endocrinol. 13:1588–1598.
   PubMedGoogle Scholar
• Li Y, et al. 2005. Crystallographic identification and functional characterization of phospholipids as ligands for the orphan nuclear receptor steroidogenic factor-1. Mol. Cell 17:491–502.
   PubMed Web of Science ®Google Scholar
• Linke T, et al. 2001. Interfacial regulation of acid ceramidase activity. Stimulation of ceramide degradation by lysosomal lipids and sphingolipid activator proteins. J. Biol. Chem. 276:5760–5768.
   PubMed Web of Science ®Google Scholar
• Lucki N, Sewer MB. 2009. The cAMP-responsive element binding protein (CREB) regulates the expression of acid ceramidase (ASAH1) in H295R human adrenocortical cells. Biochim. Biophys. Acta 1791:706–713.
   PubMedGoogle Scholar
• Lucki NC, Bandyopadhyay S, Wang E, Merrill AH, Sewer MB. 2012. Acid ceramidase (ASAH1) is a global regulator of steroidogenic capacity and adrenocortical gene expression. Mol. Endocrinol. 26:228–243.
   PubMed Web of Science ®Google Scholar
• Lucki NC, Sewer MB. 2008. Multiple roles for sphingolipids in steroid hormone biosynthesis. Subcell. Biochem. 49:387–412.
   PubMedGoogle Scholar
• Mangelsdorf DJ, et al. 1995. The nuclear receptor superfamily: the second decade. Cell 83:835–839.
   PubMed Web of Science ®Google Scholar
• McInerney EM, et al. 1998. Determinants of coactivator LXXLL motif specificity in nuclear receptor transcriptional activation. Genes Dev. 12:3357–3368.
   PubMed Web of Science ®Google Scholar
• Monté D, DeWitte F, Hum DW. 1998. Regulation of the human P450scc gene by steroidogenic factor 1 is mediated by CBP/p300. J. Biol. Chem. 273:4585–4591.
   PubMed Web of Science ®Google Scholar
• Neitcheva T, Peeva D. 1995. Phospholipid composition, phospholipase A2 and sphingomyelinase activities in rat liver nuclear membrane and matrix. Int. J. Biochem. Cell Biol. 27:995–1001.
   PubMed Web of Science ®Google Scholar
• Ozbay T, Merrill AHJr, Sewer MB. 2004. ACTH regulates steroidogenic gene expression and cortisol biosynthesis in the human adrenal cortex via sphingolipid metabolism. Endocr. Res. 30:787–794.
   PubMed Web of Science ®Google Scholar
• Ozbay T, Rowan A, Leon A, Patel P, Sewer MB. 2006. Cyclic adenosine 5′-monophosphate-dependent sphingosine-1-phosphate biosynthesis induces human CYP17 gene transcription by activating cleavage of sterol regulatory element binding protein 1. Endocrinology 147:1427–1437.
   PubMed Web of Science ®Google Scholar
• Park J, Schuchuman E. 2006. Acid ceramidase and human disease. Biochim. Biophys. Acta 1758:2133–2138.
   PubMed Web of Science ®Google Scholar
• Parker KL, et al. 2002. Steroidogenic factor 1: an essential mediator of endocrine development. Recent Prog. Horm. Res. 57:19–36.
   PubMedGoogle Scholar
• Payne AH, Hales DB. 2004. Overview of steroidogenic enzymes in the pathway from cholesterol to active steroid hormones. Endocr. Rev. 25:947–970.
   PubMed Web of Science ®Google Scholar
• Perissi V, et al. 1999. Molecular determinants of nuclear receptor-corepressor interaction. Genes Dev. 13:3198–3208.
   PubMed Web of Science ®Google Scholar
• Pettus BJ, Chalfant CE, Hannun YA. 2002. Ceramide in apoptosis: an overview and current perspectives. Biochim. Biophys. Acta 1585:114–125.
   PubMed Web of Science ®Google Scholar
• Plotnikov A, Chuderland D, Karamansha Y, Livnah O, Seger R. 2011. Nuclear extracellular signal-regulated kinase 1 and 2 translocation is mediated by casein kinase 2 and accelerated by autophosphorylation. Mol. Cell. Biol. 31:3515–3530.
   PubMed Web of Science ®Google Scholar
• Rainey WE, Bird IM, Mason JI. 1994. The NCI-H295 cell line: a pluripotent model for human adrenocortical studies. Mol. Cell. Endocrinol. 100:45–50.
   PubMed Web of Science ®Google Scholar
• Romiti E, et al. 2000. Neutral/alkaline and acid ceramidase activities are actively released by murine endothelial cells. Biochem. Biophys. Res. Commun. 275:746–751.
   PubMed Web of Science ®Google Scholar
• Rosenfeld MG, Lunyak VV, Glass CK. 2006. Sensors and signals: a coactivator/corepressor/epigenetic code for integrating signal-dependent programs of transcriptional response. Genes Dev. 20:1405–1428.
   PubMed Web of Science ®Google Scholar
• Sablin EP, et al. 2009. Structure of SF-1 bound by different phospholipids: evidence for regulatory ligands. Mol. Endocrinol. 23:25–34.
   PubMedGoogle Scholar
• Sakane F, Yamada K, Kanoh H. 1989. Different effects of sphingosine, R59022 and anionic amphiphiles on two diacylglycerol kinase isozymes purified from porcine thymus cytosol. FEBS Lett. 255:409–413.
   PubMedGoogle Scholar
• Selzner M, et al. 2001. Induction of apoptotic cell death and prevention of tumor growth by ceramide analogues in metastatic human colon cancer. Cancer Res. 61:1233–1240.
   PubMed Web of Science ®Google Scholar
• Sewer MB, et al. 2002. Transcriptional activation of human CYP17 in H295R adrenocortical cells depends on complex formation among p54(nrb)/NonO, protein-associated splicing factor, and SF-1, a complex that also participates in repression of transcription. Endocrinology 143:1280–1290.
   PubMed Web of Science ®Google Scholar
• Sewer MB, Waterman MR. 2003. ACTH modulation of transcription factors responsible for steroid hydroxylase gene expression in the adrenal cortex. Microsc. Res. Tech. 61:300–307.
   PubMed Web of Science ®Google Scholar
• Sewer MB, Waterman MR. 2002. Adrenocorticotropin/cyclic adenosine 3′,5′-monophosphate-mediated transcription of the human CYP17 gene in the adrenal cortex is dependent on phosphatase activity. Endocrinology 143:1769–1777.
   PubMed Web of Science ®Google Scholar
• Sewer MB, Waterman MR. 2002. cAMP-dependent transcription of steroidogenic genes in the human adrenal cortex requires a dual-specificity phosphatase in addition to protein kinase A. J. Mol. Endocrinol. 29:163–174.
   PubMedGoogle Scholar
• Shao D, et al. 1998. Interdomain communication regulating ligand binding by PPAR-gamma. Nature 396:377–380.
   PubMed Web of Science ®Google Scholar
• Shtraizent N, et al. 2008. Autoproteolytic cleavage and activation of human acid ceramidase. J. Biol. Chem. 283:11253–11259.
   PubMed Web of Science ®Google Scholar
• Spiegel S, Milstien S. 2002. Sphingosine 1-phosphate, a key cell signaling molecule. J. Biol. Chem. 277:25851–25854.
   PubMed Web of Science ®Google Scholar
• Staels B, Hum DW, Miller WL. 1993. Regulation of steroidogenesis in NCI-H295 cells: a cellular model of the human fetal adrenal. Mol. Endocrinol. 7:423–433.
   PubMed Web of Science ®Google Scholar
• Sullards MC. 2000. Analysis of sphingomyelin, glucosylceramide, ceramide, sphingosine, and sphingosine 1-phosphate by tandem mass spectrometry. Methods Enzymol. 312:32–45.
   PubMed Web of Science ®Google Scholar
• Sullards MC, Merrill AHJr. 2001. Analysis of sphingosine 1-phosphate, ceramides, and other bioactive sphingolipids by high-performance liquid chromatography-tandem mass spectrometry. Sci. STKE 2001:pl1.
   PubMedGoogle Scholar
• Suzuki T, Kasahara M, Yoshioka H, Morohashi K, Umesono K. 2003. LXXLL-related motifs in Dax-1 have target specificity for the orphan nuclear receptors Ad4BP/SF-1 and LRH-1. Mol. Cell. Biol. 23:238–249.
   PubMed Web of Science ®Google Scholar
• Tamiya-Koizumi K, Umekawa H, Yoshida S, Kojima K. 1989. Existence of Mg2+-dependent, neutral sphingomyelinase in nuclei of rat ascites hepatoma cells. J. Biochem. 106:593–598.
   PubMedGoogle Scholar
• Tremblay A, Tremblay GB, Labrie F, Giguere V. 1999. Ligand-independent recruitment of SRC-1 to estrogen receptor beta through phosphorylation of activation function AF-1. Mol. Cell 3:513–519.
   PubMed Web of Science ®Google Scholar
• Urs AN, et al. 2007. Steroidogenic factor-1 is a sphingolipid binding protein. Mol. Cell. Endocrinol. 265–266:174–178.
   PubMedGoogle Scholar
• Urs AN, Dammer E, Sewer M. 2006. Sphingosine regulates the transcription of CYP17 by binding to steroidogenic factor-1. Endocrinology 147:5249–5258.
   PubMed Web of Science ®Google Scholar
• Wang E, Norred WP, Bacon CW, Riley RT, Merrill AHJr. 1991. Inhibition of sphingolipid biosynthesis by fumonisins. Implications for diseases associated with Fusarium moniliforme. J. Biol. Chem. 266:14486–14490.
   PubMed Web of Science ®Google Scholar
• Wang W, et al. 2005. The crystal structures of human steroidogenic factor-1 and liver receptor homologue-1. Proc. Natl. Acad. Sci. U. S. A. 102:7505–7510.
   PubMed Web of Science ®Google Scholar
• Wattenberg BW, Pitson SM, Raben DM. 2006. The sphingosine and diacylglycerol kinase superfamily of signaling kinases: localization as a key to signaling function. J. Lipid Res. 47:1128–1139.
   PubMed Web of Science ®Google Scholar
• Winnay JN, Hammer GD. 2006. Adrenocorticotropic hormone-mediated signaling cascades coordinate a cyclic pattern of steroidogenic factor 1-dependent transcriptional activation. Mol. Endocrinol. 20:147–166.
   PubMed Web of Science ®Google Scholar
• Yazawa T, et al. 2010. PPAR-gamma coactivator-1alpha regulates progesterone production in ovarian granulosa cells with SF-1 and LRH-1. Mol. Endocrinol. 24:485–496.
   PubMedGoogle Scholar
• Zhang H, Thomsen JS, Johansson L, Gustafsson JA, Treuter E. 2000. DAX-1 functions as an LXXLL-containing corepressor for activated estrogen receptors. J. Biol. Chem. 275:39855–39859.
   PubMed Web of Science ®Google Scholar
• Zhou D, et al. 2000. PNRC: a proline-rich nuclear receptor coregulatory protein that modulates transcriptional activation of multiple nuclear receptors, including orphan receptors SF1 (steroidogenic factor 1) and ERRalpha1 (estrogen related receptor alpha-1). Mol. Endocrinol. 14:986–998.
   PubMedGoogle Scholar